6 completed, 3 terminated, 1 withdrawn. 7 Phase 1, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 7 | Completed 4, Terminated 2, Withdrawn 1 |
| Phase 2 | 3 | Completed 2, Terminated 1 |
Follow Annick Desjardins: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Phase 2 Study of Sym004 for Adult Patients With Recurrent Glioblastoma Sym004 - 18 mg/kg, Sym004 - 24 mg/kg - Malignant Glioma | Phase 2 | Completed | Annick Desjardins | 43 | 2016-02-01 | 2020-08-05 |
| Ph 1/2 CTO With Lomustine for Bevacizumab-Naive Recurrent Glioma CTO, Lomustine - Malignant Glioma (WHO Grade III or IV) | Phase 1 | Terminated | Annick Desjardins | 9 | 2014-05-01 | 2016-08-04 |
| Phase 1/2 CTO + Bevacizumab for Recurrent Glioma Post-Bevacizumab Failure CTO and Bevacizumab, CTO alone - Malignant Glioma (WHO Grade III or IV) | Phase 1 | Terminated | Annick Desjardins | 17 | 2013-10-01 | 2016-02-19 |
| Panitumumab and Irinotecan for Malignant Gliomas Irinotecan, Panitumumab - Malignant Glioma of Brain | Phase 2 | Terminated | Annick Desjardins | 16 | 2010-02-01 | 2013-09-04 |
| Pharmacokinetics (PK) Study of AC480 for Recurrent Glioma AC480 - Glioma | Phase 1 | Completed | Annick Desjardins | 5 | 2009-11-01 | 2014-01-29 |
| Bevacizumab Plus Irinotecan Plus Carboplatin for Recurrent Malignant Glioma (MG) bevacizumab and CPT-11 and Carboplatin - Malignant Glioma | Phase 2 | Completed | Annick Desjardins | 104 | 2009-09-01 | 2013-09-16 |
| Ph. I Dasatinib/Protracted Temozolomide in Recurrent Malignant Glioma enzyme-inducing anti-epileptic drugs - Glioblastoma Multiforme, Gliosarcoma | Phase 1 | Withdrawn | Annick Desjardins | 2009-06-01 | 2012-11-21 | |
| Ph I Dose Escalation Trial of Vandetanib in Combo w Etoposide for Malignant Gliomas Vandetanib and Etoposide - Gliosarcoma, Glioblastoma | Phase 1 | Completed | Annick Desjardins | 49 | 2008-02-01 | 2013-02-20 |
| Ph I Zactima + Imatinib Mesylate & Hydroxyurea for Pts w Recurrent Malignant Glioma Zactima, Gleevec, Hydroxyurea - Glioblastoma, Gliosarcoma | Phase 1 | Completed | Annick Desjardins | 27 | 2007-11-01 | 2012-12-05 |
| Ph I Gleevec in Combo w RAD001 + Hydroxyurea for Pts w Recurrent MG Gleevec, RAD001, and Hydroxyurea - Glioblastoma, Gliosarcoma | Phase 1 | Completed | Annick Desjardins | 78 | 2005-05-01 | 2013-02-20 |
Glioma (9) · Glioblastoma (7) · Gliosarcoma (6) · Brain Neoplasms (3) · Astrocytoma (2) · Lymphoma, Follicular (2) · Oligodendroglioma (2)
Bevacizumab (2) · Hydroxyurea (2) · Imatinib Mesylate (2) · Irinotecan (2) · vandetanib (2) · Carboplatin (1) · Etoposide (1) · Everolimus (1) · Lomustine (1) · Panitumumab (1) · etoposide phosphate (1) · futuximab (1)
United States (10)